Glucose control and vascular complications in veterans with type 2 diabetes

Cited by (1,057)

Items 201–300 of 1,057

1. Systematic review: glucose control and cardiovascular disease in type 2 diabetes
   Kelly, Tanika N., Bazzano, Lydia A., Fonseca, Vivian A., Thethi, Tina K., Reynolds, Kristi, He, Jiang · 2009 · Annals of Internal Medicine
2. Cardio-Metabolic Benefits of Plant-Based Diets
   Hana Kahleová, Susan Levin, Neal D. Barnard · 2017 · Nutrients
3. Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: The HEART2D trial
   Raz, Itamar, Wilson, Peter W.F., Strojek, Krzysztof, Kowalska, Irina, Bozikov, Velimir, Gitt, Anselm K., Jermendy, György, Campaigne, Barbara N., Kerr, Lisa, Milicevic, Zvonko et al. · 2009 · Diabetes Care
4. Comparison of low- and high-carbohydrate diets for type 2 diabetes management: a randomized trial
   Tay, Jeannie, Luscombe-Marsh, Natalie D, Thompson, Campbell H, Noakes, Manny, Buckley, Jonathan D, Wittert, Gary A, Yancy, William S, Brinkworth, Grant D · 2015 · The American Journal of Clinical Nutrition
5. Diagnosis and Management of Type 2 Diabetic Kidney Disease
   Simit Doshi, Allon N. Friedman · 2017 · Clinical Journal of the American Society of Nephrology
6. Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials
   Jay S. Skyler, Richard M. Bergenstal, Robert O. Bonow, John B. Buse, PRAKASH C. DEEDWANIA, Edwin AM Gale, Barbara V. Howard, Marian Sue Kirkman, Mikhail Kosiborod, Peter D. Reaven et al. · 2008 · Circulation
7. Diabetic Kidney Disease
   Sonali Gupta, Mary Dominguez, Ladan Golestaneh · 2023 · Medical Clinics of North America
8. Japanese Clinical Practice Guideline for Diabetes 2019
   Eiichi Araki, Atsushi Goto, Tatsuya Kondo, Mitsuhiko Noda, Hiroshi Noto, Hideki Origasa, Haruhiko Osawa, Akihiko Taguchi, Yukio Tanizawa, Kazuyuki Tobe et al. · 2020 · Journal of Diabetes Investigation
9. Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature
   Nalysnyk, L., Hernandez‐Medina, M., Krishnarajah, G. · 2010 · Diabetes, Obesity and Metabolism
10. Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes
    Ebenezer A. Nyenwe, Terri W. Jerkins, Guillermo E. Umpierrez, Abbas E. Kitabchi · 2010 · Metabolism
11. Glycemic Control, Complications, and Death in Older Diabetic Patients
    Elbert S. Huang, Jennifer Y. Liu, Howard H. Moffet, Priya M. John, Andrew John Karter · 2011 · Diabetes Care
12. 2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial
    Baptist Gallwitz, Julio Rosenstock, Thomas Rauch, Sudipta Bhattacharya, Sanjay Dhanji Patel, Maximilian von Eynatten, Klaus A. Dugi, Hans‐Juergen Woerle · 2012 · The Lancet
13. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
    Sacks, David B., Arnold, Mark, Bakris, George L., Bruns, David E., Horvath, Andrea R., Lernmark, Åke, Metzger, Boyd E., Nathan, David M., Kirkman, M. Sue · 2023 · Diabetes Care
14. Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and meta-analysis
    Toyama, Tadashi, Neuen, Brendon L., Jun, Min, Ohkuma, Toshiaki, Neal, Bruce, Jardine, Meg J., Heerspink, Hiddo L., Wong, Muh Geot, Ninomiya, Toshiharu, Wada, Takashi et al. · 2019 · Diabetes, Obesity and Metabolism
15. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
    Juliana C.N. Chan, LL Lim, Nicholas J. Wareham, Jonathan E. Shaw, Trevor John Orchard, Ping Zhang, Eric S. H. Lau, Björn Eliasson, Alice P.S. Kong, Majid Ezzati et al. · 2020 · Figshare
16. The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review
    Fishman, Sarah Louise, Sonmez, Halis, Basman, Craig, Singh, Varinder, Poretsky, Leonid · 2018 · Molecular Medicine
17. Markers of insulin resistance and carotid atherosclerosis. A comparison of the homeostasis model assessment and triglyceride glucose index
    Concetta Irace, Claudio Carallo, Faustina Barbara Scavelli, Maria Serena De Franceschi, T. Esposito, Cesare Tripolino, Agostino Gnasso · 2013 · International Journal of Clinical Practice
18. Standards of care for type 2 diabetes in China
    Weng, Jianping, Ji, Linong, Jia, Weiping, Lu, Juming, Zhou, Zhiguang, Zou, Dajin, Zhu, Dalong, Chen, Liming, Chen, Li, Guo, Lixin et al. · 2016 · Diabetes/Metabolism Research and Reviews
19. The Effects of Medical Management on the Progression of Diabetic Retinopathy in Persons with Type 2 Diabetes
    Emily Y. Chew, Matthew D. Davis, Ronald P. Danis, James F. Lovato, Letitia Perdue, Craig M. Greven, SAUL M. GENUTH, David Calvin Goff, Lawrence A. Leiter, Faramarz Ismail‐Beigi et al. · 2014 · Ophthalmology
20. Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial
    2014 · The Lancet Diabetes & Endocrinology
21. The Global Burden of Diabetes
    Mohammed Kumail Ali, Mary Beth Weber, K.M. Venkat Narayan · 2010 · Wiley eBooks
22. Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial
    Ueki, Kohjiro, Sasako, Takayoshi, Okazaki, Yukiko, Kato, Masayuki, Okahata, Sumie, Katsuyama, Hisayuki, Haraguchi, Mikiko, Morita, Ai, Ohashi, Ken, Hara, Kazuo et al. · 2017 · The Lancet Diabetes & Endocrinology
23. Intensive glucose control improves kidney outcomes in patients with type 2 diabetes
    Perkovic, Vlado, Heerspink, Hiddo Lambers, Chalmers, John, Woodward, Mark, Jun, Min, Li, Qiang, MacMahon, Stephen, Cooper, Mark E., Hamet, Pavel, Marre, Michel et al. · 2013 · Kidney International
24. Insulin resistance is a cardiovascular risk factor in humans
    María M. Adeva‐Andany, Julia Martínez‐Rodríguez, Manuel González-Lucán, Carlos Fernández‐Fernández, Elvira Castro-Quintela · 2019 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
25. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)
    Joep Perk, Guy De Backer, H. Gohlke, Ian M Graham, Željko Reiner, W. M. Monique Verschuren, Christian Albus, Pascale Benlian, Gudrun Boysen, Renata Cífková et al. · 2012 · International Journal of Behavioral Medicine
26. Diabetes and infection: assessing the association with glycaemic control in population-based studies
    Jonathan Pearson‐Stuttard, Samkeliso V. Blundell, Tess J Harris, Derek G. Cook, Julia Critchley · 2015 · The Lancet Diabetes & Endocrinology
27. Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes
    Lipska, Kasia J., Krumholz, Harlan, Soones, Tacara, Lee, Sei J. · 2016 · JAMA
28. Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006–2013
    Lipska, Kasia J., Yao, Xiaoxi, Herrin, Jeph, McCoy, Rozalina G., Ross, Joseph S., Steinman, Michael A., Inzucchi, Silvio E., Gill, Thomas M., Krumholz, Harlan M., Shah, Nilay D. · 2017 · Diabetes Care
29. Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association
    Arnold, Suzanne V., Bhatt, Deepak L., Barsness, Gregory W., Beatty, Alexis L., Deedwania, Prakash C., Inzucchi, Silvio E., Kosiborod, Mikhail, Leiter, Lawrence A., Lipska, Kasia J., Newman, Jonathan D. et al. · 2020 · Circulation
30. Glucose Control and Diabetic Neuropathy: Lessons from Recent Large Clinical Trials
    Lynn P. Ang, Mamta Jaiswal, Catherine L. Martin, Rodica Pop‐Busui · 2014 · Current Diabetes Reports
31. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes
    Maria Rosaria Rizzo, Michelangela Barbieri, Raffaele Marfella, Giuseppe Paolisso · 2012 · Diabetes Care
32. Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored
    John J.V. McMurray, Hertzel C. Gerstein, Rury R. Holman, Marc Alan Pfeffer · 2014 · The Lancet Diabetes & Endocrinology
33. The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus
    Joshua A. David, William J. Rifkin, Piul S. Rabbani, Daniel J. Ceradini · 2017 · Journal of Diabetes Research
34. Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes
    Yun, Jae-Seung, Ko, Seung-Hyun · 2021 · Metabolism
35. 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
    Das, Sandeep R., Everett, Brendan M., Birtcher, Kim K., Brown, Jenifer M., Cefalu, William T., Januzzi, James L., Kalyani, Rita Rastogi, Kosiborod, Mikhail, Magwire, Melissa L., Morris, Pamela B. et al. · 2018 · Journal of the American College of Cardiology
36. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus
    Fullerton, Birgit, Jeitler, Klaus, Seitz, Mirjam, Horvath, Karl, Berghold, Andrea, Siebenhofer, Andrea · 2014 · Cochrane Database of Systematic Reviews
37. Chronic kidney disease in the elderly: evaluation and management
    Mary C. Mallappallil, Eli A. Friedman, Barbara G. Delano, Samy I. McFarlane, Moro O. Salifu · 2014 · Clinical Practice
38. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm—2019 executive summary.
    Garber, Alan J., Abrahamson, Martin J., Barzilay, Joshua I., Blonde, Lawrence, Bloomgarden, Zachary T., Bush, Michael A., Dagogo-Jack, Samuel, DeFronzo, Ralph A., Einhorn, Daniel, Fonseca, Vivian A. et al. · 2019 · Endocrine Practice
39. Distal Symmetric Polyneuropathy
    Brian Christopher Callaghan, Raymond S. Price, Eva L. Feldman · 2015 · JAMA
40. SGLT2 Inhibitors and Cardiovascular Risk: Lessons Learned From the EMPA-REG OUTCOME Study
    Muhammad A Abdul‐Ghani, Stefano Del Prato, ROBERT J. CHILTON, Ralph Anthony DeFronzo · 2016 · Diabetes Care
41. Cardiovascular Complications of Diabetic Kidney Disease
    Ragnar Pálsson, Uptal D. Patel · 2014 · Advances in Chronic Kidney Disease
42. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus
    Bianca Hemmingsen, Søren Søgaard Lund, Christian Nyfeldt Gluud, Allan Arthur Vaag, Thomas Almdal, Jørn Wetterslev · 2015 · Cochrane Database of Systematic Reviews · Retracted
43. Trends in Cardiovascular Disease Risk Factors in Individuals With and Without Diabetes Mellitus in the Framingham Heart Study
    Sarah R. Preis, Michael J. Pencina, Shih‐Jen Hwang, Ralph B. D’Agostino, Peter J. Savage, Daniel A Levy, Caroline S. Fox · 2009 · Circulation
44. Updates in diabetic peripheral neuropathy
    Kelsey Juster-Switlyk, A. Gordon Smith · 2016 · F1000Research
45. Macrovascular Complications in Patients with Diabetes and Prediabetes
    Dou Huang, Marwan M. Refaat, Kamel Mohammedi, Amin Jayyousi, Jassim M. S. Al Suwaidi, Charbel Abi Khalil · 2017 · BioMed Research International
46. American Association of Clinical Endocrinologists' Comprehensive Diabetes Management Algorithm 2013 Consensus Statement - Executive Summary
    Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel E. Dagogo-Jack, Michael Davidson, DANIEL F. EINHORN, William Timothy Garvey et al. · 2013 · Endocrine Practice
47. Time in Range in Relation to All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes: A Prospective Cohort Study
    Lu, Jingyi, Wang, Chunfang, Shen, Yun, Chen, Lei, Zhang, Lei, Cai, Jinghao, Lu, Wei, Zhu, Wei, Hu, Gang, Xia, Tian et al. · 2021 · Diabetes Care
48. Peer Mentoring and Financial Incentives to Improve Glucose Control in African American Veterans: A Randomized Trial
    Long, Judith A., Jahnle, Erica C., Richardson, Diane M., Loewenstein, George, Volpp, Kevin G. · 2012 · Annals of Internal Medicine
49. Evaluating All Potential Oral Complications of Diabetes Mellitus
    Martijn J. L. Verhulst, Bruno G. Loos, Victor E. A. Gerdes, Wijnand J. Teeuw · 2019 · Frontiers in Endocrinology
50. Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global <scp>HAT</scp> study
    Khunti, K., Alsifri, S., Aronson, R., Cigrovski Berković, M., Enters‐Weijnen, C., Forsén, T., Galstyan, G., Geelhoed‐Duijvestijn, P., Goldfracht, M., Gydesen, H. et al. · 2016 · Diabetes Obesity and Metabolism
51. Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia
    Almudena Areosa Sastre, Robin W.M. Vernooij, Magali González‐Colaço Harmand, Gabriel Martínez · 2017 · Cochrane Database of Systematic Reviews
52. Obesity and hyperlipidemia are risk factors for early diabetic neuropathy
    Albert Gordon Smith, John Robinson Singleton · 2013 · Journal of Diabetes and its Complications
53. 6. Glycemic Targets
    American Diabetes Association · 2016 · Diabetes Care
54. Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis
    Κωνσταντίνος Τζιόμαλος, Vasilios Gabriel Athyros · 2015 · The Review of Diabetic Studies
55. Diabetes mellitus and cognitive impairments
    Elham Saedi, Mohammad Reza Gheini, Firoozeh Faiz, Mohammad Ali Arami · 2016 · World Journal of Diabetes
56. Peripheral neuropathy in prediabetes and the metabolic syndrome
    Amro Maher Stino, Albert Gordon Smith · 2017 · Journal of Diabetes Investigation
57. Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes
    Molitch, Mark E., Adler, Amanda I., Flyvbjerg, Allan, Nelson, Robert G., So, Wing-Yee, Wanner, Christoph, Kasiske, Bertram L., Wheeler, David C., de Zeeuw, Dick, Mogensen, Carl E. · 2015 · Kidney International
58. The Bypass Angioplasty Revascularization Investigation 2 Diabetes Randomized Trial of Different Treatment Strategies in Type 2 Diabetes Mellitus With Stable Ischemic Heart Disease: Impact of Treatment Strategy on Cardiac Mortality and Myocardial Infarction
    Chaitman, Bernard R., Hardison, Regina M., Adler, Dale, Gebhart, Suzanne, Grogan, Mary, Ocampo, Salvador, Sopko, George, Ramires, Jose A., Schneider, David, Frye, Robert L. et al. · 2009 · Circulation
59. Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes
    Ele Ferrannini, Ralph Anthony DeFronzo · 2015 · European Heart Journal
60. Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function: Data From the CANVAS Program
    Neuen, Brendon L., Ohkuma, Toshiaki, Neal, Bruce, Matthews, David R., de Zeeuw, Dick, Mahaffey, Kenneth W., Fulcher, Greg, Desai, Mehul, Li, Qiang, Deng, Hsiaowei et al. · 2018 · Circulation
61. Hypoglycemia: The neglected complication
    Kalra, Sanjay, Mukherjee, Jagat Jyoti, Venkataraman, Subramanium, Bantwal, Ganapathi, Shaikh, Shehla, Saboo, Banshi, Das, Ashok Kumar, Ramachandran, Ambady · 2013 · Indian Journal of Endocrinology and Metabolism
62. Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes
    Sophia Zoungas, Bastiaan E. de Galan, Toshiharu Ninomiya, Diederick E. Grobbee, Pavel Hamet, Simon R. Heller, Stephen W MacMahon, Michel Marre, Bruce Charles Neal, Anushka A Patel et al. · 2009 · Diabetes Care
63. Gene Silencing of the Mitochondrial Adaptor p66 Shc Suppresses Vascular Hyperglycemic Memory in Diabetes
    Francesco Paneni, Pavani Mocharla, Alexander T. Akhmedov, Sarah Costantino, Elena Osto, Massimo Volpe, Thomas Felix Lüscher, Francesco Cosentino · 2012 · Circulation Research
64. Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials
    Udell, Jacob A, Cavender, Matthew A, Bhatt, Deepak L, Chatterjee, Saurav, Farkouh, Michael E, Scirica, Benjamin M · 2015 · The Lancet Diabetes &amp; Endocrinology
65. Patient adherence to medication requirements for therapy of type 2 diabetes
    Clifford J. Bailey, M. Kodack · 2011 · International Journal of Clinical Practice
66. Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment
    Victoria A Serhiyenko, Alexandr A. Serhiyenko · 2018 · World Journal of Diabetes
67. Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies
    Jennie H. Best, Byron J. Hoogwerf, William H. Herman, Elise M. Pelletier, Daniel B. Smith, Madé Wenten, Mohamed A. Hussein · 2010 · Diabetes Care
68. Untitled work
    2015 · 10.1136/bmj.h3234
69. Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial
    The ORIGIN Trial Investigators, Mellbin, Linda G., Rydén, Lars, Riddle, Matthew C., Probstfield, Jeffrey, Rosenstock, Julio, Díaz, Rafael, Yusuf, Salim, Gerstein, Hertzel C. · 2013 · European Heart Journal
70. HbA1c and Risk of Severe Hypoglycemia in Type 2 Diabetes
    Kasia J. Lipska, E. Margaret Warton, Elbert S. Huang, Howard H. Moffet, Silvio E. Inzucchi, Harlan M. Krumholz, Andrew John Karter · 2013 · Diabetes Care
71. Association of Clinical Symptomatic Hypoglycemia With Cardiovascular Events and Total Mortality in Type 2 Diabetes
    Pai‐Feng Hsu, Shih‐Hsien Sung, Hao‐Min Cheng, Jong Shiuan Yeh, Wen‐ling Liu, Wan‐Leong Chan, Chen‐Huan Chen, Pesus Chou, Shao‐Yuan Chuang · 2012 · Diabetes Care
72. Pharmacological treatment of hyperglycemia in type 2 diabetes
    Simeon I. Taylor, Zhinous Shahidzadeh Yazdi, Amber L. Beitelshees · 2021 · Journal of Clinical Investigation
73. The Cost-Effectiveness of Preexposure Prophylaxis for HIV Prevention in the United States in Men Who Have Sex With Men
    Jessie L. Juusola · 2012 · Annals of Internal Medicine
74. Diabetic neuropathy: cutting-edge research and future directions
    Yang Yang, Bing Tian Zhao, Yuanzhe Wang, H H Lan, Xinyu Liu, Yue Hu, Peng Cao · 2025 · Signal Transduction and Targeted Therapy
75. Roux-en-Y Gastric Bypass Surgery or Lifestyle With Intensive Medical Management in Patients With Type 2 Diabetes
    Florencia Halperin, Su-Ann Ding, Donald C. Simonson, Jennifer Panosian, ANN E. GOEBEL-FABBRI, Marlene Wewalka, Osama Hamdy, Martin J. Abrahamson, Kerri A. Clancy, Kathleen Foster et al. · 2014 · JAMA Surgery
76. Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals
    Gogitidze Joy, Nino, Hedrington, Maka S., Briscoe, Vanessa J., Tate, Donna B., Ertl, Andrew C., Davis, Stephen N. · 2010 · Diabetes Care
77. A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trial
    Alexander J M Brown, Stephen J. Gandy, Rory J. McCrimmon, J. Graeme Houston, Allan D. Struthers, Chim Choy Lang · 2020 · European Heart Journal
78. Epidemiology in diabetes mellitus and cardiovascular disease
    Wenjun Fan · 2017 · Cardiovascular Endocrinology
79. Long-Term Effects of Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Surgery on Type 2 Diabetes Mellitus in Morbidly Obese Subjects
    Amanda Jiménez, Roser Casamitjana, Lílliam Flores, Judith Viaplana, Ricard Corcelles, Antonio M. Lacy, Josép Vidal · 2012 · Annals of Surgery
80. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary
    Stephan D. Fihn, Julius M. Gardin, Jonathan Abrams, Kathleen Berra, James C. Blankenship, Apostolos P. Dallas, Pamela S. Douglas, JoAnne Micale Foody, Thomas C. Gerber, Alan L. Hinderliter et al. · 2012 · Journal of the American College of Cardiology
81. Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
    Heidi Storgaard, Lise Lotte Gluud, Cathy Bennett, Magnus F.G. Grøndahl, Mikkel Christensen, Filip Krag Knop, Tina Vilsbøll · 2016 · PLoS ONE
82. Intensive Insulin Therapy in Critically Ill Patients: NICE-SUGAR or Leuven Blood Glucose Target?
    Greet Van den Berghe, Miet Schetz, Dirk Vlasselaers, Greet Hermans, Alexander P. Wilmer, Roger Bouillon, Dieter Mesotten · 2009 · The Journal of Clinical Endocrinology & Metabolism
83. Validation of the IMS CORE Diabetes Model
    Phil C. McEwan, VOLKER FOOS, James L. Palmer, Mark Lamotte, Adam Lloyd, David J.W. Grant · 2014 · Value in Health
84. Glycemic Goals in Diabetes: Trade-off Between Glycemic Control and Iatrogenic Hypoglycemia
    Philip E. Cryer · 2014 · Diabetes
85. Epidemiology of polyneuropathy in diabetes and prediabetes
    Dan Ziegler, Νικόλαος Παπάνας, Aaron I. Vinik, Jonathan E. Shaw · 2014 · Handbook of clinical neurology
86. The association of severe hypoglycemia with incident cardiovascular events and mortality in adults with type 2 diabetes
    Lee, Alexandra K., Warren, Bethany, Lee, Clare J., McEvoy, John W., Matsushita, Kunihiro, Huang, Elbert S., Sharrett, A. Richey, Coresh, Josef, Selvin, Elizabeth · 2018 · Diabetes Care
87. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD – Summary
    pre-diabetes Task Force on diabetes · 2014 · Diabetes and Vascular Disease Research
88. Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes
    Holman, Rury R, Sourij, Harald, Califf, Robert M · 2014 · The Lancet
89. Painful diabetic neuropathy
    Amanda Peltier, Stephen A. Goutman, Brian Christopher Callaghan · 2014 · BMJ
90. European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack
    Jesse Dawson, Yannick Béjot, Louisa Marguerite Christensen, Gian Marco De Marchis, Martin Dichgans, Guri Hagberg, Mirjam R. Heldner, Haralampos J. Milionis, Linxin Li, Francesca Romana Pezzella et al. · 2022 · European Stroke Journal
91. Hypoglycemia among patients with type 2 diabetes: epidemiology, risk factors, and prevention strategies
    Silbert, Richard, Salcido-Montenegro, Alejandro, Rodriguez-Gutierrez, Rene, Katabi, Abdulrahman, McCoy, Rozalina G. · 2018 · Current Diabetes Reports
92. Selective Insulin Resistance and the Development of Cardiovascular Diseases in Diabetes: The 2015 Edwin Bierman Award Lecture
    George Liang King, Kyoungmin Park, Qian Li · 2016 · Diabetes
93. Protective Factors and the Pathogenesis of Complications in Diabetes
    Marc Gregory Yu, Daniel Gordin, Jialin Fu, Kyoungmin Park, Qian Li, George Liang King · 2023 · Endocrine Reviews
94. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention &amp; Rehabilitation (EACPR)
    Authors/Task Force Members: Joep Perk (Chairperson) (Sweden)*, Guy De Backer (Belgium), Helmut Gohlke (Germany), Ian Graham (Ireland), Željko Reiner (Croatia), WM Monique Verschuren (The Netherlands), Christian Albus (Germany), Pascale Benlian (France), Gudrun Boysen (Denmark), Renata Cifkova (Czech Republic), Christi Deaton (UK), Shah Ebrahim (UK), Miles Fisher (UK), Giuseppe Germano (Italy), Richard Hobbs (UK), Arno Hoes (The Netherlands), Sehnaz Karadeniz (Turkey), Alessandro Mezzani (Italy), Eva Presco · 2012 · European Journal of Preventive Cardiology
95. Drug safety assessment in clinical trials: methodological challenges and opportunities
    Sonal Singh, Yoon Kong Loke · 2012 · Trials
96. Intensive glucose control in patients with type 2 diabetes - 15-year follow-up.
    Reaven, Peter D., Emanuele, Nicholas V., Wiitala, Wyndy L., Bahn, Gideon D., Reda, Domenic J., McCarren, Madeline, Duckworth, William C., Hayward, Rodney A. · 2019 · New England Journal of Medicine
97. Insulin Resistance as a Physiological Defense Against Metabolic Stress: Implications for the Management of Subsets of Type 2 Diabetes
    Christopher James Nolan, Neil B. Ruderman, Steven E. Kahn, Oluf Borbye Pedersen, Marc Prentki · 2015 · Diabetes
98. Diabetes and Aging: unique considerations and goals of care
    Kalyani, Rita R., Golden, Sherita H., Cefalu, William T. · 2017 · Diabetes Care
99. Pioglitazone: the forgotten, cost-effective cardioprotective drug for type 2 diabetes
    DeFronzo, Ralph A, Inzucchi, Silvio, Abdul-Ghani, Muhammad, Nissen, Steven E · 2019 · Diabetes and Vascular Disease Research
100. The “Metabolic Memory” Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic Complications
     Roberto Testa, Anna Rita Bonfigli, Francesco Prattichizzo, Lucia La Sala, Valeria De Nigris, Antonio Ceriello · 2017 · Nutrients